Atia Vision receives FDA Approval to begin clinical trial of novel intraocular lens

Atia Vision receives FDA Approval to begin clinical trial of novel intraocular lens

Atia Vision's OmniVu Lens System promises a breakthrough in cataract surgery with enhanced vision restoration.

FDA Grants Atia Vision Approval to Begin US Clinical Trial of OmniVu Lens System in Patients with Cataracts

Atia Vision has received Investigational Device Exemption (IDE) approval from the FDA to begin a traditional feasibility clinical study of its OmniVu Lens System. This novel IOL is designed to restore dynamic range of vision following cataract surgery. "This IDE approval marks a pivotal milestone in our mission to transform the standard of care for cataract patients," Mariam Maghribi, CEO of Atia Vision, said in a company news release. "OmniVu w…

Office-Based Cataract Surgery Measures Up To Ambulatory Surgery Center Cases

A retrospective review of 1300 cataract operations by one surgeon finds office-based surgeries are no less safe than ambulatory surgery center cases. Medscape Medical News